SCHEMBL447441

SCHEMBL447441

Cc1ccc(-c2ccc3c(c2-c2ccc(C)cc2)C(B(O)O)c2ccccc2-3)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.35
KMT2A Q03164 4/20 0.35
LMNA P02545 2/20 0.35
EDNRB P24530 1/20 0.35
EDNRA P25101 1/20 0.35
NPC1 O15118 3/20 0.33
RAB9A P51151 3/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.33
SYK P43405 1/20 0.33
ENPP1 P22413 1/20 0.32
COMT P21964 1/20 0.32
GPR84 Q9NQS5 1/20 0.32
POLB P06746 1/20 0.31
PTGS2 P35354 2/20 0.31
PDK2 Q15119 1/20 0.31
MAPK1 P28482 1/20 0.30
TDP1 Q9NUW8 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30
PTGS1 P23219 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18343745 0.74 GPR3 (0.32) MEN1KMT2ALMNAPOLBTDP1
SCHEMBL9020786 0.73 ALDH1A1 (0.35) MEN1KMT2ALMNAEDNRBEDNRA
SCHEMBL9863553 0.72 EDNRB (0.37) MEN1KMT2ALMNAEDNRBEDNRA
SCHEMBL5034116 0.70 GPR3 (0.34) KMT2APOLB
SCHEMBL1044055 0.70 GPR3 (0.41) MEN1KMT2ALMNAEDNRBEDNRA
SCHEMBL29953549 0.70 GPR3 (0.41) MEN1KMT2ALMNAEDNRBEDNRA
SCHEMBL9020869 0.68 PDCD1 (0.39) PDK2
SCHEMBL27659967 0.67 HDAC4 (0.40) MEN1KMT2AEDNRBEDNRAALDH1A1
SCHEMBL28139840 0.66 NPC1 (0.47) MEN1KMT2ALMNANPC1RAB9A
SCHEMBL15519390 0.66 PTGS2 (0.47) ALDH1A1ENPP1COMTPTGS2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9349960-B2 Compounds and polymers which contain substituted indenofluorene derivatives as structural unit, process for the preparation thereof, and the use thereof as electronic devices and mixtures and solutions MERCK PATENT GMBH (DE) 2016-05-24 US disclosed
US-20120061617-A1 POLYMERS WHICH CONTAIN SUBSTITUTED INDENOFLUORENE DERIVATIVES AS STRUCTURAL UNIT, PROCESS FOR THE PREPARATION THEREOF, AND THE USE THEREOF MERCK PATENT GMBH (DE) 2012-03-15 US disclosed
WO-2010136110-A2 POLYMERS COMPRISING SUBSTITUTED INDENOFLUORENE DERIVATES AS STRUCTURAL UNITS, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF MERCK PATENT GMBH (DE) 2010-12-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120061617-A1 POLYMERS WHICH CONTAIN SUBSTITUTED INDENOFLUORENE DERIVATIVES AS STRUCTURAL UNIT, PROCESS FOR THE PREPARATION THEREOF, AND THE USE THEREOF PPID, PCID2, OCIAD1 MEN1 4773/4885KMT2A 4490/4885LMNA 1722/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.